Diurnal cycle influences peripheral and brain iron levels in mice

Journal of Applied Physiology

Volumn 106, Issue 1, 2009, Pages 187-193

  Unger, Erica L ^a   Earley, Christopher J ^b   Beard, John L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Diurnal cycles; Iron deficiency; Liver iron; Restless legs syndrome; Ventral midbrain

Indexed keywords

FERRITIN; IRON;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON TRANSPORT; LIVER LEVEL; MALE; MESENCEPHALON; MOTOR CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; BODY WEIGHT; BRAIN; CIRCADIAN RHYTHM; DEFICIENCY DISEASES; DISEASE MODELS, ANIMAL; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HOMEOSTASIS; IRON; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RESTLESS LEGS SYNDROME; SEX FACTORS; SPLEEN;

EID: 58649108784     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.91076.2008     Document Type: Article

References (63)

1. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56: 263-265, 2001.
2. Allen RP, Dean T, Earley CJ. Effects of rest-duration, time-of-day and their interaction on periodic leg movements while awake in restless legs syndrome. Sleep Med 6: 429-434, 2005.
3. Anderson GJ, Darshan D, Wilkins SJ, Frazer DM. Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals 20: 665-674, 2007.
4. Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr 23: 41-58, 2003.
5. Beard JL, Wiesinger JA, Li N, Connor JR. Brain iron uptake in hypotransferrinemic mice: influence of systemic iron status. J Neurosci Res 79: 254-261, 2005.
6. Benkovic SA, Connor JR. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J Comp Neurol 338: 97-113, 1993.
7. Bjorvatn B, Leissner L, Ulfberg J, Gyring J, Karlsborg M, Regeur L, Skeidsvoll H, Nordhus IH, Pallesen S. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 6: 307-312, 2005.
8. Bradbury MW. Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 69: 443-454, 1997.
9. Burhans MS, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L, Jones BC, Beard JL. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci 8: 31-38, 2005.
10. Casale G, Migliavacca A, Bonora C, Zurita IE, de Nicola P. Circadian rhythm of plasma iron, total iron binding capacity and serum ferritin in arteriosclerotic aged patients. Age Ageing 10: 115-118, 1981.
11. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 147: 67-73, 2006.
12. Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR. Is ferroportin-hepcidin signaling altered in restless legs syndrome? J Neurol Sci 247: 173-179, 2006.
13. Collu R, Jequier JC, Letarte J, Leboeuf G, Ducharme JR. Effect of stress and hypothalamic deafferentation on the secretion of growth hormone in the rat. Neuroendocrinology 11: 183-190, 1973.
14. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61: 304-309, 2003.
15. Connor JR, Menzies SL, Burdo JR, Boyer PJ. Iron and iron management proteins in neurobiology. Pediatr Neurol 25: 118-129, 2001.
16. Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P. A quantitative analysis of isoferritins in select regions of aged, Parkinsonian, and Alzheimer's diseased brains. J Neurochem 65: 717-724, 1995.
17. Cook GA, King MT, Veech RL. Changes in liver inorganic pyrophosphate content during ethanol metabolism. Adv Exp Med Biol 132: 433-440, 1980.
18. Crowe A, Morgan EH. Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 592: 8-16, 1992.
19. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72-81, 2008.
20. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 62: 623-628, 2000.
21. Earley CJ, Connor JR, Beard JL, Clardy SL, Allen RP. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep 28: 1069-1075, 2005.
22. Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5: 231-235, 2004.
23. Earley CJ, Horska A, Mohamed MA, Barker PB, Beard JL, Allen RP. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med. In press.
24. Earley CJ, Barker PB, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 7: 458-461, 2006.
25. Erikson KM, Jones BC, Beard JL. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130: 2831-2837, 2000.
26. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 69: 409-418, 2001.
27. Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 18: 299-304, 1987.
28. Fox RR, Laird CW. Biochemical parameters of clinical significance in rabbits. II. Diurnal variations. J Hered 61: 265-268, 1970.
29. Fox RR, Laird CW, Kirshenbaum J, Meier H. Effect of strain, sex, and circadian rhythm on rabbit serum bilirubin and iron levels. Proc Soc Exp Biol Med 145: 421-427, 1974.
30. Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord 22: 187-192, 2007.
31. Han J, Day JR, Connor JR, Beard JL. Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats. Nutz Neurosci 6: 1-10, 2003.
32. Han J, Day JR, Thomson K, Connor JR, Beard JL. Iron deficiency alters H- and L-ferritin expression in rat brain. Cell Mol Biol (Noisy-le-grand) 46: 517-528, 2000.
33. Hutchins DA, Rogers KJ. Some observations on the circadian rhythm of locomotor activity of mice after depletion of cerebral monoamines. Psy-chopharmacologia 31: 343-348, 1973.
34. Johannes F, Blizard DA, Lionikas A, Lang DH, Vandenbergh DJ, Stout JT, Strauss JA, McClearn GE, Vogler GP. QTL influencing baseline hematocrit in the C57BL/6J and DBA/2J lineage: age-related effects. Mamm Genome 17: 689-699, 2006.
35. Jones BC, Beard JL, Gibson JN, Unger EL, Allen RP, McCarthy KA, Earley CJ. Systems genetic analysis of peripheral iron parameters in the mouse. Am J Physiol Regul Integr Comp Physiol 293: R116-R124, 2007.
36. Jones BC, Reed CL, Hitzemann R, Wiesinger JA, McCarthy KA, Buwen JP, Beard JL. Quantitative genetic analysis of ventral midbrain and liver iron in BXD recombinant inbred mice. Nutr Neurosci 6: 369-377, 2003.
37. Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53: 620-628, 2007.
38. Kuvibidila SR, Porretta C. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells. J Cell Biochem 86: 571-582, 2002.
39. Malecki EA, Devenyi AG, Beard JL, Connor JR. Existing and emerging mechanisms for transport of iron and manganese to the brain. J Neu-rosci Res 56: 113-122, 1999.
40. Moos T. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375: 675-692, 1996.
41. Moos T, Morgan EH. The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J Neu-rochem 88: 233-245, 2004.
42. Moos T, Morgan EH. Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol 20: 77-95, 2000.
43. Nelson C, Erikson K, Pinero DJ, Beard JL. In vivo dopamine metabolism is altered in iron-deficient anemic rats. J Nutr 127: 2282-2288, 1997.
44. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276, 2004.
45. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
46. Nichols DA, Allen RP, Grauke JH, Brown JB, Rice ML, Hyde PR, Dement WC, Kushida CA. Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 163: 2323-2329, 2003.
47. O'Keeffe ST, Egan D, Myers A, Redmond S. The frequency and impact of restless legs syndrome in primary care. Ir Med J 100: 539 -542, 2007.
48. Patrick LR. Restless legs syndrome: pathophysiology and the role of iron and folate. Altern Med Rev 12: 101-112, 2007.
49. Pietrangelo A, Trautwein C. Mechanisms of disease: the role of hepcidin in iron homeostasis-implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 1: 39-45, 2004.
50. Pinero D, Jones B, Beard J. Variations in dietary iron alter behavior in developing rats. J Nutr 131: 311-318, 2001.
51. Pinero DJ, Li NQ, Connor JR, Beard JL. Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr 130: 254-263, 2000.
52. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993.
53. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106: 2196-2199, 2005.
54. Scales WE, Vander AJ, Brown MB, Kluger MJ. Human circadian rhythms in temperature, trace metals, and blood variables. J Appl Physiol 65: 1840-1846, 1988.
55. Schmidauer C, Sojer M, Seppi K, Stockner H, Hogl B, Biedermann B, Brandauer E, Peralta CM, Wenning GK, Poewe W. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 58: 630-634, 2005.
56. Simon ML, George R. Diurnal variations in plasma corticosterone and growth hormone as correlated with regional variations in norepinephrine, dopamine and serotonin content of rat brain. Neuroendocrinology 17: 125-138, 1975.
57. Sleipness EP, Sorg BA, Jansen HT. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: dependence on the suprachiasmatic nucleus. Brain Res 1129: 34-42, 2007.
58. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 21: 371-377, 1998.
59. Taylor EM, Morgan EH. Role of transferrin in iron uptake by the brain: a comparative study. J Comp Physiol [B] 161: 521-524, 1991.
60. Uchida T, Akitsuki T, Kimura H, Tanaka T, Matsuda S, Kariyone S. Relationship among plasma iron, plasma iron turnover, and reticuloendothelial iron release. Blood 61: 799-802, 1983.
61. Unger EL, Beard JL, Jones BC. Iron regulation in C57BLI6 and DBA/2 mice subjected to iron overload. Nutr Neurosci 10: 89-95, 2007.
62. 62a. Wang Q, DUF, Qian ZM, Ge XH, Zhu L, Yung WH, Yang L, Ke Y. Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology. 149: 3920-3925, 2008.
63. Zoller H, Theurl I, Koch R, Kaser A, Weiss G. Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis 29: 488-497, 2002.